Clinical trials
PeptideScanner retained ClinicalTrials.gov record NCT05520775 at 2026-07-30T18:29:04.228Z. Its registry update date was 2025-04-02, and PeptideScanner's reviewed identity mapping was semaglutide.↗
PeptideScanner retained ClinicalTrials.gov record NCT05520775 at 2026-07-30T18:29:04.228Z. Its registry update date was 2025-04-02, and PeptideScanner's reviewed identity mapping was semaglutide. 1
This page reports a dated retained registry observation and does not assert the record's current status; registration is not evidence that an intervention is safe or effective. 1
Complete submitted registry timeline
ClinicalTrials.gov lists these public versions with submitted dates from August 26, 2022 through March 25, 2025. Each entry links to the exact public source version and reports only the source-declared status, study type, dates, and changed-module labels.
Source-declared changed modules: None listed for this version
Source-declared changed modules: Outcome Measures, Sponsor/Collaborators, Study Identification, Study Status
Source-declared changed modules: Study Status
Source-declared changed modules: Contacts/Locations, Eligibility, Study Description, Study Status
Source-declared changed modules: Contacts/Locations, Study Design, Study Status
Source-declared changed modules: Study Status
Source-declared changed modules: Document Section, Study Status
Source-declared changed modules: Document Section, Outcome Measures, Outcome Measures (Results), Study Status
Source-declared changed modules: Baseline Characteristics, Document Section, Outcome Measures, Outcome Measures (Results), Study Status
ClinicalTrials.gov · Official source · Source checked August 9, 2026